Infiltración transtimpánica de corticoides para el tratamiento de los acúfenos subjetivos en pacientes del Hospital de Clínicas de Julio-Agosto 2021

Authors

  • Ricardo Serrano-Andrade Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay https://orcid.org/0000-0001-7912-3393
  • Carlos Mena Canata Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay https://orcid.org/0000-0003-4429-4840
  • Ta Ju Liu Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay
  • Raúl Tornaco-Maidana Universidad Nacional de Asunción, Facultad de Ciencias Médicas, San Lorenzo, Paraguay

DOI:

https://doi.org/10.52379/mcs.v6i2.250

Keywords:

corticosteroids, Injection, dexamethasone, tinnitus

Abstract

Introduction: Tinnitus is a problem that affects an important part of the population, whose causes are not entirely clear. Currently there is no cure or consensus on the treatment of tinnitus, which is ineffective in many cases, is accompanied by significant side effects or does not provide symptomatic relief to patients. Intratympanic injection of corticosteroids has been reported to improve symptoms. Objective: to determine the result of transtympanic infiltration of corticosteroids for the treatment of subjective tinnitus. Methods: The design of the study is observational, descriptive and correlational, sampling was non-probabilistic of consecutive cases. Adult patients with unilateral or bilateral tinnitus of more than one month of evolution as the main symptom were included. Results: 25 patients were included in the research, most of them were male with a mean age of approximately 45 years. The main type of hearing loss associated with these patients was sensorineural. No audiometric differences were found between pre and post infiltration. Conclusion: A large percentage of patients had a high degree of disability due to tinnitus and moderate to severe symptoms prior to treatment, after which this decreased, but not significantly.

Downloads

Download data is not yet available.

References

Esmaili AA, Renton J. A review of tinnitus. Aust J Gen Pract. abril de 2018;47(4):205-8. https://doi.org/10.31128/AJGP-12-17-4420

Shim HJ. Intratympanic Steroid Injection in Tinnitus Management. Hanyang Med Rev. 25 de mayo de 2016;36(2):125-30. https://doi.org/10.7599/hmr.2016.36.2.125

Savage J, Waddell A. Tinnitus. BMJ Clin Evid. 2014;2014:0506. URL.

Elzayat S, El-Sherif H, Hegazy H, Gabr T, El-Tahan AR. Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids. ORL J Otorhinolaryngol Relat Spec. 2016;78(3):159-66. https://doi.org/10.1159/000445774

Araújo MFS, Oliveira CA, Bahmad FM. Intratympanic Dexamethasone Injections as a Treatment for Severe, Disabling Tinnitus: Does It Work? Arch Otolaryngol Head Neck Surg. 2005;131(2):113. https://doi.org/10.1001/archotol.131.2.113

Sayoo C, Kumar S. Intratympanic Injection of Steroid for Treatment of Tinnitus. Indian J Otolaryngol Head Neck Surg. 2019;71(S2):1123-5. https://doi.org/10.1007/s12070-017-1213-3

Yener HM, Sar? E, Aslan M, Yollu U, Gözen ED, ?nci E. The Efficacy of Intratympanic Steroid Injection in Tinnitus Cases Unresponsive to Medical Treatment. J Int Adv Otol. 2020;16(2):197-200. https://doi.org/10.5152/iao.2020.7588

Peña Martínez A. Evaluación de la incapacidad provocada por el tinnitus: homologación lingüística nacional del Tinnitus Handicap Inventory (THI). Rev Otorrinolaringol Cir Cabeza Cuello. 2006;66(3):232–5. http://dx.doi.org/10.4067/S0718-48162006000300009

Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngol Head Neck Surg. 2014;151(4):533-41. https://doi.org/10.1177/0194599814547475

Sakata H, Kojima Y, Koyama S, Furuya N, Sakata E. Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity. Int Tinnitus J. 2001;7(1):46-50. URL.

Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D. Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience. Int Tinnitus J. 2002;8(2):111-4. URL.

She W, Dai Y, Du X, Chen F, Ding X, Cui X. Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. Med Sci Monit. 2009;15(6):PI35-39. URL.

Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz HB, Ozbay M, Kulekci M. Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol. 2009;123(11):1221-5. https://doi.org/10.1017/S0022215109990685

Shim HJ. Intratympanic Steroid Injection in Tinnitus Management. Hanyang Med Rev. 2016;36(2):125. https://doi.org/10.7599/hmr.2016.36.2.125

Baguley D, McFerran D, Hall D. Tinnitus. Lancet. 2013;382(9904):1600-7. https://doi.org/10.1016/S0140-6736(13)60142-7

Peña Martínez A. Evaluación de la incapacidad provocada por el tinnitus: homologación lingüística nacional del Tinnitus Handicap Inventory (THI). Revista de otorrinolaringología y cirugía de cabeza y cuello. 2006;66(3):232-5. http://dx.doi.org/10.4067/S0718-48162006000300009

Published

05/05/2022

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.